一个试点随机对照试验在线癌症丧亲团体的协议
Lara King1, Kirsten Smith2,3,4, Charles L Cole5
1Division of Psychology & Lang Sciences, Faculty of Brain Sciences, Research department of Clinical Educational and Health Psychology (CEHP), University College London (UCL), London, UK. Lara.king.23@ucl.ac.uk.
Pilot and feasibility studies
|February 26, 2026
概括
这项试点研究评估了成年人由治疗师领导的在线癌症哀悼小组. 研究结果表明,这些在线干预措施是可行的和可以接受的,可能会改善心理结果.
科学领域:
- 心理学 心理学 心理学
- 在线干预 在线干预
- 悲伤研究 悲伤研究
背景情况:
- 癌症丧带来了独特的挑战,对亲自支持的有效性有有限的证据.
- 传统支持的障碍包括耻辱和地理位置,强调需要可访问的替代方案.
- 在线干预提供了一个可行的解决方案,但由治疗师领导的在线癌症哀悼小组需要进一步调查.
研究的目的:
- 评估治疗师领导的在线小组干预对因癌症丧生的成年人的可行性和可接受性.
- 探索这种在线支持的潜在心理益处.
- 为未来大规模随机对照试验 (RCT) 的设计提供信息.
主要方法:
- 一个纵向试点随机受控试验 (RCT),涉及100名因癌症丧生的成年人.
- 参与者被随机分配到即时或延迟 (3个月) 干预组.
- 一个八个会议的在线治疗小组 (12周) 整合了CBT,以同情心为中心的治疗和悲伤模型.
主要成果:
- 主要结果集中在可行性 (招聘,留住,坚持) 和可接受性 (出席率,帮助度等级).
- 其次结果包括悲伤强度的变化,抑郁,焦虑,PTSD,自我同情和社会断绝.
- 探索性分析检查了干预后和3个月后期心理结果的群体间差异.
结论:
- 这项试点试验将确定由治疗师领导的在线癌症哀悼小组的可行性和可接受性.
- 与等候名单对照组相比,预计心理结果的假设改善,具有持续的影响.
- 这些发现将指导开发一个全面的RCT,以确定治疗疗效.
相关概念视频
Cancer Survival Analysis
805
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
805
Randomized Experiments
9.1K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
9.1K
Clinical Trials: Overview
5.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.1K
Clinical Trials
10.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.9K
Comparing the Survival Analysis of Two or More Groups
674
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
674
Hazard Ratio
661
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
661


